May 20, 2026 04:06PM
Apr 22, 2026 06:41AM
Apr 21, 2026 10:46AM
Apr 1, 2026 07:09AM
Mar 23, 2026 06:01AM
Mar 17, 2026 06:47AM
Mar 9, 2026 06:36AM Raymond James on Eupraxia Pharmaceuticals (EPRX): 'We See an Attractive Setup for 2026 Into Ph2b RESOLVE EoE Data'
Feb 23, 2026 04:35PM
Feb 19, 2026 04:48PM
Jan 15, 2026 07:20AM
Jan 8, 2026 07:34AM
Nov 14, 2025 07:03AM
Nov 13, 2025 05:00PM
Oct 2, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Eupraxia Pharmaceuticals (EPRX)
Sep 30, 2025 06:52AM
Sep 29, 2025 05:00PM
Sep 26, 2025 06:47AM
Sep 2, 2025 08:02AM
Aug 20, 2025 06:39AM
Jun 26, 2025 06:07AM
Jun 16, 2025 11:15AM Canaccord Genuity Starts Eupraxia Pharmaceuticals (EPRX:CN) (EPRX) at Spec. Buy
Feb 25, 2025 07:01AM
Feb 21, 2025 09:05AM
Feb 18, 2025 07:00AM
Nov 14, 2024 06:43AM
Oct 15, 2024 07:00AM
Oct 2, 2024 05:01PM
Sep 11, 2024 07:01AM Eupraxia Pharmaceuticals (EPRX) Reports Data from RESOLVE Phase 1b/2a Trial of EP-104GI

408,536 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All